Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

about

Recent advances in understanding and treating chronic granulomatous disease.Primary Immunodeficiency Diseases: Current and Emerging Therapeutics.Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.

P2860

Q40059524-6D66F263-9995-4BF9-A722-92054F66AFC8 Q40076704-27DA1B75-3E76-4123-B6AF-7F6410E5536A Q55233801-E3176C7A-247C-4B2D-9A4C-E441399FA028

P2860

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

Item

http://www.wikidata.org/entity/Q41646698

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

@en

type

Item

label

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

@en

prefLabel

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

@en

P1476

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

@en

P2093

David B Lewis

http://www.w3.org/2001/XMLSchema#string

K T Park

http://www.w3.org/2001/XMLSchema#string

P2860

Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis

Chronic granulomatous disease: a review of the infectious and inflammatory complications.

Current concepts of hyperinflammation in chronic granulomatous disease.

Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.

Inflammation and repeated infections in CGD: two sides of a coin.

Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Gastrointestinal involvement in chronic granulomatous disease.

P2888

s10875-016-0318-x

P304

619-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-016-0318-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manish J. Butte

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027838655

http://www.w3.org/2001/XMLSchema#string

P698

27465505

http://www.w3.org/2001/XMLSchema#string

P932

5018915

http://www.w3.org/2001/XMLSchema#string

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

about

P2860

P2860

Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932